minimal residual disease testing

1 articles
The Motley FoolThe Motley Fool··Cory Renauer

Harvest Investment Exits $5.7M ADPT Position Amid Strong 57% Annual Rally

Harvest Investment Services exits $5.7M position in Adaptive Biotechnologies despite stock's 57.78% annual rally. $ADPT remains strong operationally with growing cancer diagnostics segment.
PLTRADPTbiotechnologystock sale